Fig. 2.
Fig. 2. Pathway of cell differentiation and proliferative capacity of BM DCs. / (A) CD11c+CD86− BM DCs are the immediate precursors of CD11c+CD86+ DCs, whereas double-negative cells are the progenitors of CD11c+CD86− DCs. BM cells cultured in GM-CSF + IL-4 (day 7) were labeled with PE anti-CD11c and FITC anti-CD86, FACS-sorted into CD11c+CD86− DCs (upper row) and into double-negative cells (lower row), and recultured in GM-CSF + IL-4 for 24 hours. Numbers outside quadrants indicate percentages of cells. (B) Proliferative capacity of CD11c− CD86−, CD11c+CD86−, and CD11c+CD86+ BM-derived cells. BM cells cultured with GM-CSF + IL-4 (day 7) were labeled, FACS-sorted, and grown with medium, GM-CSF (GM), GM-CSF + IL-4 (GM + IL-4), or IL-4 (3 × 104 cells/well). Proliferation was assessed by3H-TdR incorporation after 3 days of culture. Results are representative of 3 experiments.

Pathway of cell differentiation and proliferative capacity of BM DCs.

(A) CD11c+CD86 BM DCs are the immediate precursors of CD11c+CD86+ DCs, whereas double-negative cells are the progenitors of CD11c+CD86 DCs. BM cells cultured in GM-CSF + IL-4 (day 7) were labeled with PE anti-CD11c and FITC anti-CD86, FACS-sorted into CD11c+CD86 DCs (upper row) and into double-negative cells (lower row), and recultured in GM-CSF + IL-4 for 24 hours. Numbers outside quadrants indicate percentages of cells. (B) Proliferative capacity of CD11c CD86, CD11c+CD86, and CD11c+CD86+ BM-derived cells. BM cells cultured with GM-CSF + IL-4 (day 7) were labeled, FACS-sorted, and grown with medium, GM-CSF (GM), GM-CSF + IL-4 (GM + IL-4), or IL-4 (3 × 104 cells/well). Proliferation was assessed by3H-TdR incorporation after 3 days of culture. Results are representative of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal